Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

  • Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    • News

  • Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    • News

  • Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    • News

  • Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    • News

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

Explain Like I’m 5: Trading vs Investing

  • In Opinion
  • May 11, 2021
  • Samantha Freidin
Explain Like I’m 5: Trading vs Investing

If you explore the world of the share market for more than two minutes you’re bound to come across the words “investing” and “trading”. But what is the difference between the two of them and how do you decide which is right for you? Let’s start with the basics.

What is trading? 

Trading involves frequent transactions with the aim of generating quick profits that outperform that of buy-and-hold investing. Traders seek to make profits within a certain amount of time.

There are four subcategories of trading:

  • Position Trading: positions are held from months to years
  • Swing Trading: positions are held from days to weeks
  • Day Trading: positions are held throughout the day only
  • Scalp Trading: positions are held for seconds to minutes

What is investing?

Investing is more of a long term strategy and seeks steady returns through buying and holding stocks. The goal of investing is to gradually build up wealth over time from a diverse portfolio of stocks. Investments are often held for longer periods and can generate income from the payment of dividends. Investors will hold their stocks without plans to sell in the near future and ride out downtrends in the market with the expectation that their stocks will recover and perform in the long term.

What are the main differences between the two? 

Traders and investors differ in three key ways: time frame, activity and risk tolerance.

Traders are highly active on their trading platforms, watch their portfolios and buy and sell almost daily.

They see the market as a place to realise quick, short term gains. Investors will check the market infrequently in comparison and only make a handful of trades each year.

Investors are usually more risk averse, and aim to have diversified portfolios to mitigate losses.

With higher returns comes more risk so trading is by nature, riskier than investing.

Traders manage this risk by setting rules for themselves on when to buy and sell. They will often empoy stop loss orders to get out of a trade when a stock’s value hits a certain level.

How do traders and investors choose to buy stocks?

Investors rely on fundamental analysis while traders rely on technical analysis.

Fundamental analysis is concerned with the stock’s intrinsic value and analyses the value of the company and the industry as well as patterns in the company’s financial performance. This type of analysis is both quantitative and qualitative and will take into account a broad range of factors from the current economy to the company’s individual management.

Technical analysis is the study of market action and is based around patterns in a company’s share price. This type of analysis uses historical price charts and market volumes to predict what might happen next.

How do I know which type of strategy is right for me?

The choice between trading or investing is a personal one that must take into account the level of risk you’re comfortable with, the amount of time you have to spend and your lifestyle. The split between trading and investing isn’t always black and white. Traders might buy and hold a particular stock, and investors might sell a stock shortly after buying if they perceive the stock to be overvalued.

Ultimately, investing and trading aren’t mutually exclusive. The most important thing when deciding on your primary strategy is to educate yourself on the difference and requirements of both investing and trading.

Watch the video below for more information on the difference between trading and investing.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • Opinion

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.